Please wait while the formulary information is being retrieved.
LAMOTRIGINE ODT (LAMOTRIGINE)
- Bipolar disorder in remission
- Simple-partial epilepsy
- Tonic-clonic epilepsy
- Complex-partial epilepsy
- Lennox-gastaut epilepsy
100 mg disintegrating tablet
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
200 mg disintegrating tablet
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
25 mg disintegrating tablet
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
50 mg disintegrating tablet
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
lamotrigine 100 mg disintegrating tablet
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
lamotrigine 200 mg disintegrating tablet
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
lamotrigine 25 mg disintegrating tablet
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
lamotrigine 50 mg disintegrating tablet
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
100 mg disintegrating tablet
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
200 mg disintegrating tablet
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
25 mg disintegrating tablet
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
50 mg disintegrating tablet
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
Bipolar disorder in remission
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every other day
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- Place 1 tablet (25 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (25 mg) on top of the tongue where it will dissolve, then swallow by translingual route every other day
- Place 2 tablets (50 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (50 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- Place 1 tablet (50 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- 2 tablets (50 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily
- 2 tablets (50 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 2 times per day
- Place 2 tablets (50 mg) on top of tongue, allow to dissolve then swallow by translingual route once daily
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- Place 1 tablet (100 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 2 tablets (100 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 2 tablets (100 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 2 tablets (100 mg) and place on top of the tongue where they will dissolve, then swallow by oral route 2 times per day
- 2 tablets (100 mg) and place on top of the tongue where they will dissolve, then swallow by oral route once daily
- Place 3 tablets (150 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 3 tablets (150 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 3 tablets (150 mg) and place on top of the tongue where they will dissolve, then swallow by oral route once daily
- 3 tablets (150 mg) and place on top of the tongue where they will dissolve, then swallow by oral route 2 times per day
- Place 2 tablets (200 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- 2 tablets (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (200 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (200 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
Complex-partial epilepsy
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every other day
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- Place 1 tablet (25 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (25 mg) on top of the tongue where it will dissolve, then swallow by translingual route every other day
- Place 2 tablets (50 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (50 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- Place 1 tablet (50 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- 2 tablets (50 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily
- 2 tablets (50 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 2 times per day
- Place 2 tablets (50 mg) on top of tongue, allow to dissolve then swallow by translingual route once daily
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (100 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (100 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- Place 2 tablets (100 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 2 tablets (100 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 2 tablets (100 mg) and place on top of the tongue where they will dissolve, then swallow by oral route 2 times per day
- 2 tablets (100 mg) and place on top of the tongue where they will dissolve, then swallow by oral route once daily
- Place 3 tablets (150 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 3 tablets (150 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 3 tablets (150 mg) and place on top of the tongue where they will dissolve, then swallow by oral route once daily
- 3 tablets (150 mg) and place on top of the tongue where they will dissolve, then swallow by oral route 2 times per day
- 2 tablets (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 2 tablets (200 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- 2 tablets (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 2 tablets (200 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- Place 1 tablet (200 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (200 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
Lennox-gastaut epilepsy
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every other day
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- Place 1 tablet (25 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (25 mg) on top of the tongue where it will dissolve, then swallow by translingual route every other day
- Place 2 tablets (50 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (50 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- Place 1 tablet (50 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- 2 tablets (50 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily
- 2 tablets (50 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 2 times per day
- Place 2 tablets (50 mg) on top of tongue, allow to dissolve then swallow by translingual route once daily
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (100 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (100 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- Place 2 tablets (100 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 2 tablets (100 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 2 tablets (100 mg) and place on top of the tongue where they will dissolve, then swallow by oral route 2 times per day
- 2 tablets (100 mg) and place on top of the tongue where they will dissolve, then swallow by oral route once daily
- Place 3 tablets (150 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 3 tablets (150 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 3 tablets (150 mg) and place on top of the tongue where they will dissolve, then swallow by oral route once daily
- 3 tablets (150 mg) and place on top of the tongue where they will dissolve, then swallow by oral route 2 times per day
- 2 tablets (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 2 tablets (200 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- 2 tablets (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 2 tablets (200 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- Place 1 tablet (200 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (200 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
Simple-partial epilepsy
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every other day
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- Place 1 tablet (25 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (25 mg) on top of the tongue where it will dissolve, then swallow by translingual route every other day
- Place 2 tablets (50 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (50 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- Place 1 tablet (50 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- 2 tablets (50 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily
- 2 tablets (50 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 2 times per day
- Place 2 tablets (50 mg) on top of tongue, allow to dissolve then swallow by translingual route once daily
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (100 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (100 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- Place 2 tablets (100 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 2 tablets (100 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 2 tablets (100 mg) and place on top of the tongue where they will dissolve, then swallow by oral route 2 times per day
- 2 tablets (100 mg) and place on top of the tongue where they will dissolve, then swallow by oral route once daily
- Place 3 tablets (150 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 3 tablets (150 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 3 tablets (150 mg) and place on top of the tongue where they will dissolve, then swallow by oral route once daily
- 3 tablets (150 mg) and place on top of the tongue where they will dissolve, then swallow by oral route 2 times per day
- 2 tablets (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 2 tablets (200 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- 2 tablets (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 2 tablets (200 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- Place 1 tablet (200 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (200 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
Tonic-clonic epilepsy
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every other day
- 1 tablet (25 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- Place 1 tablet (25 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (25 mg) on top of the tongue where it will dissolve, then swallow by translingual route every other day
- Place 2 tablets (50 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (50 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (50 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- Place 1 tablet (50 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- 2 tablets (50 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily
- 2 tablets (50 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 2 times per day
- Place 2 tablets (50 mg) on top of tongue, allow to dissolve then swallow by translingual route once daily
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (100 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (100 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (100 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- Place 2 tablets (100 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 2 tablets (100 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 2 tablets (100 mg) and place on top of the tongue where they will dissolve, then swallow by oral route 2 times per day
- 2 tablets (100 mg) and place on top of the tongue where they will dissolve, then swallow by oral route once daily
- Place 3 tablets (150 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 3 tablets (150 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- 3 tablets (150 mg) and place on top of the tongue where they will dissolve, then swallow by oral route once daily
- 3 tablets (150 mg) and place on top of the tongue where they will dissolve, then swallow by oral route 2 times per day
- 2 tablets (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 2 tablets (200 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- 2 tablets (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (200 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 2 tablets (200 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- Place 1 tablet (200 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (200 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- None
Contraindicated
- Depacon
- Depakene
- Depakote
- Depakote Er
- Depakote Sprinkles
- divalproex
- Stavzor
- valproate sodium
- valproic acid
- valproic acid (as sodium salt)
Severe
Moderate
- Activella
- Alora
- Altavera (28)
- Alyacen 1/35 (28)
- Alyacen 7/7/7 (28)
- Amethia
- Amethia Lo
- Amethyst
- Angeliq
- Apri
- Aranelle (28)
- Aubra
- Aviane
- Azurette (28)
- Balziva (28)
- Belladonna-phenobarbital
- Beyaz
- Brevicon (28)
- Briellyn
- Camila
- Camrese
- Camrese Lo
- carbamazepine
- Carbatrol
- Caziant (28)
- Cenestin
- Cerebyx
- Chateal
- Climara
- Climara Pro
- Combipatch
- conj estrogens-bazedoxifene
- conjugated estrogens
- Covaryx
- Covaryx H.s.
- Cryselle (28)
- Cyclafem 1/35 (28)
- Cyclafem 7/7/7 (28)
- Cyclessa (28)
- Dasetta 1/35 (28)
- Dasetta 7/7/7 (28)
- Daysee
- Delestrogen
- Depo-estradiol
- desog-e.estradiol/e.estradiol
- Desogen
- desogestrel-ethinyl estradiol
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Divigel
- Donnatal
- drospirenone-e.estradiol-lm.FA
- drospirenone-estradiol
- drospirenone-ethinyl estradiol
- Duavee
- Eemt
- Eemt Hs
- Elestrin
- Elinest
- Emoquette
- Enjuvia
- Enpresse
- Enskyce
- Epitol
- Equetro
- Errin
- Estarylla
- esterified estrogens
- Estrace
- estradiol
- estradiol cypionate
- Estradiol Transdermal Patch
- estradiol valerate
- estradiol valerate-dienogest
- estradiol-levonorgestrel
- estradiol-norethindrone acet
- estradiol-norgestimate
- Estrasorb
- Estrogel
- estrogens-methyltestosterone
- estropipate
- Estrostep Fe-28
- ethynodiol diac-eth estradiol
- etonogestrel-ethinyl estradiol
- Evamist
- Falmina (28)
- Femcon Fe
- Femhrt Low Dose
- fosphenytoin
- Generess Fe
- Gianvi (28)
- Gildagia
- Gildess
- Gildess Fe
- Heather
- Introvale
- isoniazid-rifamp-pyrazinamide
- Jencycla
- Jinteli
- Jolessa
- Jolivette
- Junel 1.5/30 (21)
- Junel 1/20 (21)
- Junel Fe 1.5/30 (28)
- Junel Fe 1/20 (28)
- Kaletra
- Kariva (28)
- Kelnor 1/35 (28)
- Kurvelo
- L norgest&E estradiol-E estrad
- Larin 1/20 (21)
- Larin Fe
- Leena 28
- Lessina
- Levonest (28)
- levonorg-eth estrad triphasic
- levonorgestrel
- levonorgestrel-ethinyl estrad
- Levora 0.15/30 (28)
- Levora-28
- Lo Loestrin Fe
- Loestrin 1.5/30 (21)
- Loestrin 1/20 (21)
- Loestrin Fe 1.5/30 (28)
- Loestrin Fe 1/20 (28)
- Lomedia 24 Fe
- lopinavir-ritonavir
- Loryna (28)
- Loseasonique
- Low-ogestrel (28)
- Luminal
- Lutera (28)
- Lyza
- Marlissa
- Menest
- Menostar
- Microgestin 1.5/30 (21)
- Microgestin 1/20 (21)
- Microgestin Fe 1.5/30 (28)
- Microgestin Fe 1/20 (28)
- Mimvey
- Minastrin 24 Fe
- Minivelle
- Mircette (28)
- Modicon (28)
- Mono-linyah
- Mononessa (28)
- My Way
- Mysoline
- Myzilra
- Natazia
- Necon 0.5/35 (28)
- Necon 1/35 (28)
- Necon 1/50 (28)
- Necon 10/11 (28)
- Necon 7/7/7 (28)
- Next Choice One Dose
- Nor-qd
- Nora-be
- norelgestrom-ethinyl estradiol
- noreth-ethinyl estradiol-iron
- norethin-e.estradiol triphasic
- norethin-eth estrad biphasic
- norethindrone (contraceptive)
- norethindrone ac-eth estradiol
- norethindrone-e.estradiol-iron
- norethindrone-ethin estradiol
- norethindrone-mestranol
- norgestimate-ethinyl estradiol
- norgestrel-ethinyl estradiol
- Norinyl 1+35 (28)
- Norinyl 1+50 (28)
- Nortrel 0.5/35 (28)
- Nortrel 1/35 (21)
- Nortrel 1/35 (28)
- Nortrel 7/7/7 (28)
- Norvir
- Norvir Soft Gelatin
- Nuvaring
- Ocella
- Ogen 2.5
- Ogestrel (28)
- Orsythia
- Ortho Evra
- Ortho Micronor
- Ortho Tri-cyclen (28)
- Ortho Tri-cyclen Lo (28)
- Ortho-cept (28)
- Ortho-cyclen (28)
- Ortho-novum 1/35 (28)
- Ortho-novum 7/7/7 (28)
- Ovcon-35 (28)
- phenobarb-hyoscy-atropine-scop
- phenobarbital
- phenobarbital sodium
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- Philith
- Pimtrea (28)
- Pirmella
- Plan B One-step
- Portia
- Prefest
- Premarin
- Previfem
- primidone
- Quartette
- Quasense
- Reclipsen (28)
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- Rifater
- ritonavir
- Safyral
- Seasonique
- Sprintec (28)
- Sronyx
- Syeda
- synthetic conj estrogens A
- synthetic conj estrogens B
- Tegretol
- Tegretol Xr
- Tilia Fe
- Tri-estarylla
- Tri-legest Fe
- Tri-linyah
- Tri-norinyl (28)
- Tri-previfem (28)
- Tri-sprintec (28)
- Trinessa (28)
- Trivora (28)
- Velivet Triphasic Regimen (28)
- Vestura (28)
- Viorele (28)
- Vivelle-dot
- Vyfemla (28)
- Wera (28)
- Wymzya Fe
- Yasmin (28)
- Yaz 28
- Zarah
- Zenchent (28)
- Zenchent Fe
- Zeosa
- Zovia 1/35E (28)
- Zovia 1/50E (28)
- None
Contraindicated
- Brugada syndrome
- Disease of liver
- Non-infective meningitis
- Suicidal ideation
Severe
Moderate
- Anemia
- Aplastic anemia
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Depression
- Kidney disease with likely reduction in GFR
- Neutropenic disorder
- Thrombocytopenic disorder
LAMOTRIGINE ODT (LAMOTRIGINE)
- Bipolar disorder in remission
- Simple-partial epilepsy
- Tonic-clonic epilepsy
- Complex-partial epilepsy
- Lennox-gastaut epilepsy
- Fever
- Skin rash
- Acute abdominal pain
- Ataxia
- Back pain
- Blurred vision
- Chest pain
- Diplopia
- Dizziness
- Drowsy
- Fatigue
- Headache disorder
- Infection
- Insomnia
- Nausea
- Pharyngitis
- Rhinitis
- Tremor
- Vomiting
- Xerostomia
More Frequent
Severe
Less Severe
- Accidental injury
- Altered mental status
- CNS toxicity
- Hemorrhage
- Irritability
- Acute confusion
- Anorexia
- Arthralgias
- Constipation
- Diarrhea
- Dysmenorrhea
- Dyspepsia
- Mood changes
- Neck pain
- Nystagmus
- Pain
- Symptoms of anxiety
- Vaginitis
- Visual changes
- Weight loss
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute eruptions of skin
- Acute renal failure
- Agranulocytosis
- Alcohol intolerance
- Anemia
- Angioedema
- Aplastic anemia
- Apnea
- Blood dyscrasias
- DRESS syndrome
- Dyskinesia
- Eosinophilia
- Epididymitis
- Erythema multiforme
- Esophagitis
- Exfoliative dermatitis
- Gastrointestinal hemorrhage
- Hearing loss
- Hemolytic anemia
- Hemophagocytic lymphohistiocytosis
- Hemorrhagic colitis
- Hyperbilirubinemia
- Hypersensitivity drug reaction
- Hypertension
- Hypogammaglobulinemia
- Immunosuppression
- Increased alanine transaminase
- Increased aspartate transaminase
- Leukopenia
- Lupus-like syndrome
- Multiple organ failure
- Neoplasm of breast
- Neutropenic disorder
- Non-infective meningitis
- Orthostatic hypotension
- Pancreatitis
- Pancytopenia
- Petechiae
- Pure red cell aplasia
- Rhabdomyolysis
- ST segment changes
- Status epilepticus
- Stevens-johnson syndrome
- Suicidal
- Suicidal ideation
- Thrombocytopenic disorder
- Tongue swelling
- Toxic epidermal necrolysis
- Uveitis
- Vasculitis
Less Severe
- Acne vulgaris
- Aggressive behavior
- Alopecia
- Amblyopia
- Aphthous stomatitis
- Arthritis
- Blepharoptosis
- Bloody vomit
- Bullous dermatitis
- Bursitis
- Chills
- Cramps in legs
- Cystitis
- Drug-induced hot flash
- Dry eye
- Dysarthria
- Dyschromia
- Dysgeusia
- Dysphagia
- Dysuria
- Earache
- Ecchymosis
- Eructation
- Erythema
- Flushing
- Galactorrhea not associated with childbirth
- Gastritis
- General weakness
- Gingival hyperplasia
- Gingivitis
- Glossitis
- Goiter
- Hallucinations
- Herpes zoster
- Hiccups
- Hirsutism
- Hostility
- Hyperglycemia
- Hyperkinesis
- Hyperventilation
- Hypothyroidism
- Increased appetite
- Loss of taste
- Lymphadenopathy
- Maculopapular rash
- Malaise
- Memory impairment
- Motor tic disorder
- Muscle atrophy
- Muscle weakness
- Nocturia
- Orgasm disorder
- Palpitations
- Panic disorder
- Paresthesia
- Parosmia
- Photophobia
- Pruritus of skin
- Sinusitis
- Skin hypopigmentation
- Sleep disorder
- Stomatitis
- Syncope
- Tachycardia
- Tinnitus
- Twitching
- Urinary retention
- Urinary urgency
- Urticaria
- Vasodilation of blood vessels
- Yawning
Contraindicated
None
Severe Precaution
Lamotrigine
Increased risk of infection, severe rash, apnea and other respiratory adverse reactions. Not indicated for age < 2 years. Safety and efficacy not demonstrated.
- 1 Day – 2 Years
- Increased risk of infection, severe rash, apnea and other respiratory adverse reactions. Not indicated for age < 2 years. Safety and efficacy not demonstrated.
Management or Monitoring Precaution
Lamotrigine (immed.release)
Monitor for rare risk of life threatening rash, hemophagocytic lymphohistiocytosis, organ failure, infection, aseptic meningitis.
- 2 Years – 18 Years
- Monitor for rare risk of life threatening rash, hemophagocytic lymphohistiocytosis, organ failure, infection, aseptic meningitis.
Lamotrigine
- Severity Level:
2
- Additional Notes: Available human data show no increased risk for major birth defects.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Lamotrigine
Monitor infant for toxicity; apnea, rash, drowsiness, poor sucking reported.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Drug shown to have adverse effect | Monitor infant for toxicity; apnea, rash, drowsiness, poor sucking reported. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Lamotrigine
Neuro/Psych-Use caution in elderly with a history of recurrent falls. Drug may produce ataxia, impaired psychomotor function, syncope, and additional falls. General-Start at the low end of the adult dosage range for elderly.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | Y | N | Y | N | N |
BEERS: Y HEDIS: Y STOPP: Y
No Known Risk
None
- Rarely, serious (sometimes fatal) skin rashes have occurred while taking this medication. These rashes are more common in children than in adults. Rashes may be more likely if you start at too high a dose, if you increase your dose too quickly, or if you take this medication with certain other anti-seizure medications (valproic acid, divalproex).<br /><br />These rashes may occur anytime during use, but most serious rashes have occurred within 2 to 8 weeks of starting lamotrigine. Get medical help right away if you develop any type of skin rash, or if you have other signs of a serious allergic reaction such as hives, fever, swollen lymph nodes, painful sores in the mouth or around the eyes, swelling of the face/tongue/throat, trouble breathing, or liver problems (symptoms include stomach/abdominal pain, nausea/vomiting that continues, dark urine, yellowing eyes/skin). Your doctor will tell you if you should stop taking lamotrigine. Even after you stop taking this, it is still possible for a rash to become life-threatening or cause permanent scars or other problems.
| Bipolar disorder in remission | |
| F31.7 | Bipolar disorder, currently in remission |
| F31.70 | Bipolar disorder, currently in remission, most recent episode unspecified |
| F31.71 | Bipolar disorder, in partial remission, most recent episode hypomanic |
| F31.72 | Bipolar disorder, in full remission, most recent episode hypomanic |
| F31.73 | Bipolar disorder, in partial remission, most recent episode manic |
| F31.74 | Bipolar disorder, in full remission, most recent episode manic |
| F31.75 | Bipolar disorder, in partial remission, most recent episode depressed |
| F31.76 | Bipolar disorder, in full remission, most recent episode depressed |
| F31.77 | Bipolar disorder, in partial remission, most recent episode mixed |
| F31.78 | Bipolar disorder, in full remission, most recent episode mixed |
| Complex-partial epilepsy | |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| Lennox-gastaut epilepsy | |
| G40.81 | Lennox-gastaut syndrome |
| G40.812 | Lennox-gastaut syndrome, not intractable, without status epilepticus |
| G40.814 | Lennox-gastaut syndrome, intractable, without status epilepticus |
| Simple-partial epilepsy | |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.1 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures |
| G40.10 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable |
| G40.109 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus |
| G40.11 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable |
| G40.119 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus |
| Tonic-clonic epilepsy | |
| G40.3 | Generalized idiopathic epilepsy and epileptic syndromes |
| G40.30 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable |
| G40.309 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.31 | Generalized idiopathic epilepsy and epileptic syndromes, intractable |
| G40.319 | Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G40.4 | Other generalized epilepsy and epileptic syndromes |
| G40.40 | Other generalized epilepsy and epileptic syndromes, not intractable |
| G40.409 | Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.41 | Other generalized epilepsy and epileptic syndromes, intractable |
| G40.419 | Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus |
| 0-9 | A-Z |
|---|---|
| F31.7 | Bipolar disorder, currently in remission |
| F31.70 | Bipolar disorder, currently in remission, most recent episode unspecified |
| F31.71 | Bipolar disorder, in partial remission, most recent episode hypomanic |
| F31.72 | Bipolar disorder, in full remission, most recent episode hypomanic |
| F31.73 | Bipolar disorder, in partial remission, most recent episode manic |
| F31.74 | Bipolar disorder, in full remission, most recent episode manic |
| F31.75 | Bipolar disorder, in partial remission, most recent episode depressed |
| F31.76 | Bipolar disorder, in full remission, most recent episode depressed |
| F31.77 | Bipolar disorder, in partial remission, most recent episode mixed |
| F31.78 | Bipolar disorder, in full remission, most recent episode mixed |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.1 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures |
| G40.10 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable |
| G40.109 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus |
| G40.11 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable |
| G40.119 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| G40.3 | Generalized idiopathic epilepsy and epileptic syndromes |
| G40.30 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable |
| G40.309 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.31 | Generalized idiopathic epilepsy and epileptic syndromes, intractable |
| G40.319 | Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G40.4 | Other generalized epilepsy and epileptic syndromes |
| G40.40 | Other generalized epilepsy and epileptic syndromes, not intractable |
| G40.409 | Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.41 | Other generalized epilepsy and epileptic syndromes, intractable |
| G40.419 | Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G40.81 | Lennox-gastaut syndrome |
| G40.812 | Lennox-gastaut syndrome, not intractable, without status epilepticus |
| G40.814 | Lennox-gastaut syndrome, intractable, without status epilepticus |
Formulary Reference Tool